Gut microbiota-derived imidazole propionate predicts cardiometabolic risk in patients with coronary artery disease.

Wenzl FA, Wang P, Kahles F, Beck KR, Giannitsis E, Obeid S, Bruno F, Li XS, Nanchen D, Liberale L, Smolle MA, Schweiger V, Klingenberg R, Manka R, Stähli BE, Templin C, König M, Yuan J, Yildirim M, Lehrke M, von Eckardstein A, Marx N, Mach F, Räber L, Katus HA, Steinhagen-Thiessen E, Demuth I, Deanfield J, Libby P, Hazen SL, Haghikia A, Landmesser U, Bäckhed F, Lüscher TF, SPUM-ACS, CLEVER-ACS, Heidelberg II-ACS and LipidCardio Investigators

Open source

DOI: 10.1093/eurheartj/ehaf661
Published: 2026 Aug 14
Container: European heart journal
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/eurheartj/ehaf661,
  title = {Gut microbiota-derived imidazole propionate predicts cardiometabolic risk in patients with coronary artery disease.},
  author = {Wenzl FA and Wang P and Kahles F and Beck KR and Giannitsis E and Obeid S and Bruno F and Li XS and Nanchen D and Liberale L and Smolle MA and Schweiger V and Klingenberg R and Manka R and Stähli BE and Templin C and König M and Yuan J and Yildirim M and Lehrke M and von Eckardstein A and Marx N and Mach F and Räber L and Katus HA and Steinhagen-Thiessen E and Demuth I and Deanfield J and Libby P and Hazen SL and Haghikia A and Landmesser U and Bäckhed F and Lüscher TF and SPUM-ACS, CLEVER-ACS, Heidelberg II-ACS and LipidCardio Investigators},
  year = {2026},
  journal = {European heart journal},
  doi = {10.1093/eurheartj/ehaf661},
  url = {https://doi.org/10.1093/eurheartj/ehaf661}
}

RIS

TY  - JOUR
TI  - Gut microbiota-derived imidazole propionate predicts cardiometabolic risk in patients with coronary artery disease.
AU  - Wenzl FA
AU  - Wang P
AU  - Kahles F
AU  - Beck KR
AU  - Giannitsis E
AU  - Obeid S
AU  - Bruno F
AU  - Li XS
AU  - Nanchen D
AU  - Liberale L
AU  - Smolle MA
AU  - Schweiger V
AU  - Klingenberg R
AU  - Manka R
AU  - Stähli BE
AU  - Templin C
AU  - König M
AU  - Yuan J
AU  - Yildirim M
AU  - Lehrke M
AU  - von Eckardstein A
AU  - Marx N
AU  - Mach F
AU  - Räber L
AU  - Katus HA
AU  - Steinhagen-Thiessen E
AU  - Demuth I
AU  - Deanfield J
AU  - Libby P
AU  - Hazen SL
AU  - Haghikia A
AU  - Landmesser U
AU  - Bäckhed F
AU  - Lüscher TF
AU  - SPUM-ACS, CLEVER-ACS, Heidelberg II-ACS and LipidCardio Investigators
PY  - 2026
JO  - European heart journal
DO  - 10.1093/eurheartj/ehaf661
UR  - https://doi.org/10.1093/eurheartj/ehaf661
ER  -

APA

FA, W., P, W., F, K., KR, B., E, G., S, O., F, B., XS, L., D, N., L, L., MA, S., V, S., R, K., R, M., BE, S., C, T., M, K., J, Y., M, Y., M, L., A, V. E., N, M., F, M., L, R., HA, K., E, S., I, D., J, D., P, L., SL, H., A, H., U, L., F, B., TF, L., & Investigators, S. C. H. I. A. L. (2026). Gut microbiota-derived imidazole propionate predicts cardiometabolic risk in patients with coronary artery disease.. European heart journal. https://doi.org/10.1093/eurheartj/ehaf661

Source records

pubmed · retrieved 2026-09-26T22:49:22.171Z
europe-pmc · retrieved 2026-09-26T22:49:22.182Z